Physician profile
Amber E Cantrell Pearson
NPI 1164182937
$544.76
in general payments reported to CMS, 2019-2025
9 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $51.12 · 2024: $30.75 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.77 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $255.61 | 2024-2025 | Veozah |
| Insulet Corporation | $142.77 | 2024-2025 | Omnipod, Omnipod |
| Abbvie INC. | $35.15 | 2025 | |
| Corcept Therapeutics | $27.68 | 2025 | Korlym |
| Regeneron Healthcare Solutions, INC. | $21.76 | 2023 | Evkeeza |
| Viatris Specialty LLC | $16.95 | 2025 | Yupelri |
| Corium, LLC | $15.48 | 2025 | Azstarys |
| Organon LLC | $14.80 | 2023 | Nexplanon |
| Janssen Pharmaceuticals, INC | $14.56 | 2023 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Cantrell Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.